Castrate Resistant Prostate Cancer is advanced disease that has stopped responding to hormone therapy. This issue of the Urologic Clinics focuses on the various forms of therapy including immunotherapy, first line chemotherapy, and novel targeted agents. Articles on defining the diseae and palliative care are also included.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. CME Accreditation Page and Author Disclosure - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 6 7. Foreword - p. 7 8. Preface - p. 8 9. Biology of Castration-Recurrent Prostate Cancer - p. 9 10. Targeting the Androgen Receptor - p. 20 11. Immunotherapy for Castration-Resistant Prostate Cancer - p. 29 12. Moving Toward Personalized Medicine in Castration-Resistant Prostate Cancer - p. 41 13. Palliative Care in Castrate-Resistant Prostate Cancer - p. 47 14. Quality of Life with Advanced Metastatic Prostate Cancer - p. 57 15. Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer - p. 66 16. Bone-Targeted Agents - p. 78 17. Targeting Angiogenesis as a Promising Modality for the Treatment of Prostate Cancer - p. 86 18. Advanced Clinical States in Prostate Cancer - p. 95 19. The Experience with Cytotoxic Chemotherapy in Metastatic Castration-Resistant Prostate Cancer - p. 104 20. Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer - p. 111 21. Index - p. 118
Castrate Resistant Prostate Cancer is advanced disease that has stopped responding to hormone therapy. This issue of the Urologic Clinics focuses on the various forms of therapy including immunotherapy, first line chemotherapy, and novel targeted agents. Articles on defining the diseae and palliative care are also included.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. CME Accreditation Page and Author Disclosure - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 6 7. Foreword - p. 7 8. Preface - p. 8 9. Biology of Castration-Recurrent Prostate Cancer - p. 9 10. Targeting the Androgen Receptor - p. 20 11. Immunotherapy for Castration-Resistant Prostate Cancer - p. 29 12. Moving Toward Personalized Medicine in Castration-Resistant Prostate Cancer - p. 41 13. Palliative Care in Castrate-Resistant Prostate Cancer - p. 47 14. Quality of Life with Advanced Metastatic Prostate Cancer - p. 57 15. Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer - p. 66 16. Bone-Targeted Agents - p. 78 17. Targeting Angiogenesis as a Promising Modality for the Treatment of Prostate Cancer - p. 86 18. Advanced Clinical States in Prostate Cancer - p. 95 19. The Experience with Cytotoxic Chemotherapy in Metastatic Castration-Resistant Prostate Cancer - p. 104 20. Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer - p. 111 21. Index - p. 118
